NOV 06, 2020 7:30 AM PST

New Vaccine Shows Promise for Herpes

WRITTEN BY: Annie Lennon

The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexually-transmitted version of herpes responsible for genital herpes. With no vaccine currently available, researchers from the US have created a new vaccine for the virus that has shown promise in early trials. 

The vaccine consists of a genetically edited form of Herpes Simplex Virus Type 1 (HSV-1), known to cause cold sores on the lips. In particular, the researchers modified region 2 (R2) of the virus, preventing it from advancing deep into the nervous system, where it causes havoc. 

For their study, the researchers tested the vaccine on guinea pigs with HSV-2. They also tested another promising vaccine candidate for HSV-2 on another groups of guinea pigs, and a placebo as a control. 

Not only did the R2 vaccine lead to a significant increase in the number of virus-combatting antibodies in the animals; it also left them with fewer lesions on their genitals, less viral replication, and less viral shedding, something that leads to viral spread to others. 

All in all, the researchers found that just one of the 12 guinea pigs injected with the R2-modified form of HSV-1 developed acute lesions, whereas five of the 12 receiving another promising vaccine candidate developed lesions. The R2 vaccine also reduced the number of days in which the guinea pigs were able to shed the virus from 29 days to 13, whereas the other vaccine candidate had no effect. 

What's more, the researchers also found that guinea pigs receiving the R2 vaccine showed no signs of HSV-2 in the cluster of brain cells they are normally found post-infection. They also found that those who received the R2 vaccine had three times the levels of neutralizing antibodies of those inoculated with the other vaccine. 

“The fact that the viral shedding was knocked down so much with the R2 vaccine is really important, because it’s the viral shedding — even if it doesn’t cause lesions - that can then pass on the virus,” says Gary Pickard, one of the authors of the study. 

“If you have genital herpes, you can pass that on to your significant other, not knowing that you’re doing it. It’s very problematic. So the fact that the shedding was knocked down so much is a really good sign.”

The researchers say that the vaccine could also work in cattle and hogs, where it can cause respiratory disease and curb appetite at a high cost to the livestock industry. While a vaccine for herpes virus currently exists for livestock, it suffers from inefficacies that, they believe, the R2 vaccine could address. 

 

Sources: Medical XpressSci-Tech Daily

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 02, 2020
Immunology
Stop the Clot: A New Antibody Treatment for Thrombosis
OCT 02, 2020
Stop the Clot: A New Antibody Treatment for Thrombosis
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
NOV 11, 2020
Health & Medicine
A smart path for novel biologics
NOV 11, 2020
A smart path for novel biologics
Introduction  Cell culture is at the heart of the production process for many biopharmaceuticals, but finding the o ...
NOV 03, 2020
Cardiology
A New Peptide Could Help Repair and Protect the Heart During Ischemia Reperfusion Injury
NOV 03, 2020
A New Peptide Could Help Repair and Protect the Heart During Ischemia Reperfusion Injury
Cardiovascular disease is one of the most common causes of death in the world. Although we have many treatments against ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
NOV 25, 2020
Drug Discovery & Development
Improving Drug Dissolution
NOV 25, 2020
Improving Drug Dissolution
When you take your medicine, it travels through the bloodstream and releases its effects. When the drug dissolves too fa ...
Loading Comments...